Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.765
+0.045 (1.65%)
At close: Feb 11, 2026, 4:00 PM EST
2.720
-0.045 (-1.63%)
After-hours: Feb 11, 2026, 7:34 PM EST
Alaunos Therapeutics Market Cap
Alaunos Therapeutics has a market cap or net worth of $6.17 million as of February 11, 2026. Its market cap has increased by 112.79% in one year.
Market Cap
6.17M
Enterprise Value
3.95M
1-Year Change
112.79%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since September 22, 2006, Alaunos Therapeutics's market cap has decreased from $76.30M to $6.17M, a decrease of -91.91%. That is a compound annual growth rate of -12.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 6.10M | -15.28% |
| Dec 31, 2025 | 7.20M | 132.26% |
| Dec 31, 2024 | 3.10M | -81.76% |
| Dec 29, 2023 | 17.00M | -87.88% |
| Dec 30, 2022 | 140.30M | -40.45% |
| Dec 31, 2021 | 235.60M | -56.37% |
| Dec 31, 2020 | 540.00M | -36.81% |
| Dec 31, 2019 | 854.50M | 220.88% |
| Dec 31, 2018 | 266.30M | -54.69% |
| Dec 29, 2017 | 587.70M | -16.61% |
| Dec 30, 2016 | 704.80M | -35.20% |
| Dec 31, 2015 | 1.09B | 108.89% |
| Dec 31, 2014 | 520.70M | 43.36% |
| Dec 31, 2013 | 363.20M | 9.66% |
| Dec 31, 2012 | 331.20M | 9.71% |
| Dec 30, 2011 | 301.90M | 33.41% |
| Dec 31, 2010 | 226.30M | 198.94% |
| Dec 31, 2009 | 75.70M | 510.48% |
| Dec 31, 2008 | 12.40M | -83.49% |
| Dec 31, 2007 | 75.10M | -17.56% |
| Dec 29, 2006 | 91.10M | 19.40% |
| Sep 22, 2006 | 76.30M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 6.90M |
| Alzamend Neuro | 6.80M |
| Creative Medical Technology Holdings | 6.71M |
| Aptorum Group | 6.65M |
| Purple Biotech | 6.63M |
| Quoin Pharmaceuticals | 6.46M |
| Mustang Bio | 6.40M |
| Calidi Biotherapeutics | 5.97M |